0000899243-15-002782.txt : 20150811 0000899243-15-002782.hdr.sgml : 20150811 20150811114616 ACCESSION NUMBER: 0000899243-15-002782 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150811 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001631650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452748244 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 BUSINESS PHONE: (650) 614-5220 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD STREET 2: SUITE 300 CITY: BRISBANE STATE: CA ZIP: 94005-1884 FORMER COMPANY: FORMER CONFORMED NAME: Allergen Research Corp DATE OF NAME CHANGE: 20150123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tananbaum James B. CENTRAL INDEX KEY: 0001581754 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043056 MAIL ADDRESS: STREET 1: 3052 PACIFIC AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foresite Capital Fund III, L.P. CENTRAL INDEX KEY: 0001645158 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043057 BUSINESS ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foresite Capital Management III, LLC CENTRAL INDEX KEY: 0001645157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043058 BUSINESS ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foresite Capital Fund II, L.P. CENTRAL INDEX KEY: 0001594914 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043059 BUSINESS ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Foresite Capital Management II, LLC CENTRAL INDEX KEY: 0001594912 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37519 FILM NUMBER: 151043060 BUSINESS ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 101 CALIFORNIA STREET, SUITE 4100 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-11 0 0001631650 Aimmune Therapeutics, Inc. AIMT 0001594912 Foresite Capital Management II, LLC 101 CALIFORNIA STREET SUITE 4100 SAN FRANCISCO CA 94111 0 0 1 0 0001594914 Foresite Capital Fund II, L.P. 101 CALIFORNIA STREET SUITE 4100 SAN FRANCISCO CA 94111 0 0 1 0 0001645157 Foresite Capital Management III, LLC 101 CALIFORNIA STREET SUITE 4100 SAN FRANCISCO CA 94111 0 0 1 0 0001645158 Foresite Capital Fund III, L.P. 101 CALIFORNIA STREET SUITE 4100 SAN FRANCISCO CA 94111 0 0 1 0 0001581754 Tananbaum James B. 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115 0 0 1 0 Common Stock, $0.0001 par value 2015-08-11 4 C 0 3775400 A 3775400 I See Footnote Common Stock, $0.0001 par value 2015-08-11 4 P 0 312500 16.00 A 4087900 I See Footnote Common Stock, $0.0001 par value 2015-08-11 4 P 0 312500 16.00 A 312500 I See Footnote Common Stock, $0.0001 par value 2015-08-11 4 P 0 17035 20.4989 A 329535 I See Footnote Series B Convertible Preferred Stock 2015-08-11 4 C 0 3775400 D Common Stock 3775400 0 I See Footnote The Series B Convertible Preferred Stock automatically converted into shares of Issuer's Common Stock on a 1 for 1 basis upon the closing of Issuer's initial public offering. Shares are owned directly by Foresite Capital Fund II, L.P. ("FCF II"). Foresite Capital Management II, LLC ("FCM II"), the Designated Filer and general partner of FCF II, may be deemed to have the sole voting and dispositive power over these shares. James Tananbaum ("Mr. Tananbaum"), in his capacity as managing member of FCM II, may be deemed to have the sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM II and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM II and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose. FCF II purchased an additional 312,500 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share. FCF III purchased 312,500 shares of Issuer's common stock in connection with the initial public offering at the offering price of $16.00 per share. Shares are owned directly by Foresite Capital Fund III, L.P. ("FCF III"). Foresite Capital Management III, LLC ("FCM III"), the general partner of FCF III, may be deemed to have the sole voting and dispositive power over these shares. James Tananbaum ("Mr. Tananbaum"), in his capacity as managing member of FCM III, may be deemed to have the sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM III and its members and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III and its members or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose. The Series B Convertible Preferred Stock has no expiration date. FORESITE CAPITAL MANAGEMENT II, LLC, By: /s/ Dennis D. Ryan, Dennis D. Ryan, Chief Financial Officer 2015-08-11 FORESITE CAPITAL FUND II, L.P., By: Foresite Capital Management II, LLC, Its General Partner, By: /s/ Dennis D. Ryan, Dennis D. Ryan, Chief Financial Officer 2015-08-11 FORESITE CAPITAL MANAGEMENT III, LLC, By: /s/ Dennis D. Ryan, Dennis D. Ryan, Chief Financial Officer 2015-08-11 FORESITE CAPITAL FUND III, L.P., By: Foresite Capital Management III, LLC, Its General Partner, By: /s/ Dennis D. Ryan, Dennis D. Ryan, Chief Financial Officer 2015-08-11 /s/ James B. Tananbaum 2015-08-11 EX-99.1 2 attachment1.htm EX-99.1 DOCUMENT

                                                                    Exhibit 99.1

        Pursuant to General Instruction number 4(b)(v) to Form 4, the following
additional reporting persons are covered by this joint filing:

Name:      Foresite Capital Fund II, L.P.
           Foresite Capital Management III, LLC
           Foresite Capital Fund III, L.P.
           James B. Tananbaum

Address:   Foresite Capital
           101 California Street
           Suite 4100
           San Francisco, CA 94111

Designated Filer:    Foresite Capital Management II, LLC

Issuer and Ticker Symbol:     Aimmune Therapeutics, Inc. (AIMT)

Date of Event Requiring Statement:  August 11, 2015


Signature:                          FORESITE CAPITAL MANAGEMENT II, LLC

                                    By: /s/ Dennis D. Ryan
                                        ---------------------------------------
                                        Dennis D. Ryan
                                        Chief Financial Officer


                                    FORESITE CAPITAL FUND II, L.P.

                                    By: Foresite Capital Management II, LLC
                                        Its General Partner


                                    By: /s/ Dennis D. Ryan
                                        ---------------------------------------
                                        Dennis D. Ryan
                                        Chief Financial Officer


                                    FORESITE CAPITAL MANAGEMENT III, LLC

                                    By: /s/ Dennis D. Ryan
                                        ---------------------------------------
                                        Dennis D. Ryan
                                        Chief Financial Officer


                                    FORESITE CAPITAL FUND III, L.P.

                                    By: Foresite Capital Management III, LLC
                                        Its General Partner


                                    By: /s/ Dennis D. Ryan
                                        ---------------------------------------
                                        Dennis D. Ryan
                                        Chief Financial Officer


                                    /s/ James B. Tananbaum
                                    -------------------------------------------
                                    James B. Tananbaum